NCT02444949View on ClinicalTrials.gov

A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2019

Conditions
Nasopharyngeal Neoplasms
Interventions
DRUG

endostar

RADIATION

intensity modulated radiation

DRUG

cisplatin

All Listed Sponsors
lead

China Three Gorges University, Yichang, China

OTHER

NCT02444949 - A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter